No Detail Found!

Increase in activity of Na+, K+-ATPase by Porphyrin compounds as treatment for Dysnatremias caused by Diabetes Mellitus.

Author(s)
Abdul-Hai Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Northern Border University, Arar, Saudi Arabia
Nadeem Kizilbash Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Northern Border University, Arar, Saudi Arabia
Abstract
Objective: The aim of this study was to test the action of Porphyrin compounds, Tetraphenylporphine sulfonate (TPPS), 5,10,15,20-Tetrakis (4-sulfonatophenyl) porphyrinato Iron(III) Chloride (FeTPPS) and 5,10,15,20-Tetrakis (4-sulfonatophenyl) porphyrinato Iron(III) nitrosyl Chloride (FeNOTPPS), on Na+ , K+ -ATPase of cell membrane of erythrocytes. Methods: Enzymatic assays, measuring the amount of inorganic phosphate produced, were used to estimate the activity of Na+ , K+ -ATPase. Results: The results show that Porphyrin compounds exert an insulin-like effect on Na+ , K+ -ATPase. They act by increasing the activity of the membrane-bound enzyme. Conclusion: All the three Porphyrin compounds increased the activity of erythrocyte Na+ , K+ -ATPase. The exact mechanism of action of these compounds is not clear.
Publication Details
Page(s) 1131-1134
DOI DOI not available
Published Journal: Pakistan Journal of Medical Research, Volume: 55, Issue: 5, Year: 2016

Request the full text from PASTIC

0

Citations

0

Downloads

23

Views